NEOG

Neogen (NEOG) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

Deals

Neogen's 10-Q Drops Its Closing Target For The Zoetis Genomics Sale; Two Regulators Now Run To December

Australian and New Zealand reviews of the Genomics divestiture are both in a second phase, with the company expecting them to end by December's close.

Deals

Neogen Lifts Fiscal 2027 Revenue Outlook To $885 Million-$890 Million Despite $11.9 Million Quarterly Loss

Core sales grew 8.1% and adjusted earnings doubled to $0.08 a share, while a year-ago divestiture gain did not repeat.